In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents

Thiazolidinediones (TZDs), used to treat type 2 diabetes mellitus, act as full agonists of the peroxisome proliferator-activated receptor gamma. Unfortunately, they produce adverse effects, including weight gain, hepatic toxicity, and heart failure. Our group previously reported the design, synthesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alemán-González-Duhart, Diana, Álvarez-Almazán, Samuel, Valdes, Miguel, Tamay-Cach, Feliciano, Mendieta-Wejebe, Jessica Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741387/
https://www.ncbi.nlm.nih.gov/pubmed/35003235
http://dx.doi.org/10.1155/2021/5100531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741387/
https://www.ncbi.nlm.nih.gov/pubmed/35003235
http://dx.doi.org/10.1155/2021/5100531

Ejemplares similares